This article examines the debate over screening for glaucoma which was has been routine in the U.S. since 2002. Three years later, a government-sponsored panel said it couldn't find any advantage or disadvantage to glaucoma screening as it related to quality of life and therefore would not recommend for or against the tests. Afraid that this finding would stop insurance companies paying for the screening, the Potomac Institute and Glaucoma Foundation released national guidelines for testing and treatment.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados